Pfizer wins the final nullification trial on the use patent of Lyrica

Published: 2016-01-18 14:34:37

Updated: 2016-01-18 14:34:37

Pfizer has won the final nullification trial filed by generic companies on the use patent of ‘Lyrica(generic name: pregabalin).’ The Supreme Court made a final ruling the use patent of Lyrica was valid on the 14^th.

Under the final ruling of the Supreme Court, the Lyrica’s treatment of pains, such as peripheral nerve disorder pains, fibromyalgia syndrome and postherpetic neuralgia, will be prot...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.

Pfizer wins the final nullification trial on the use patent of Lyrica

Pfizer has won the final nullification trial filed by generic companies on the use patent of ‘Lyrica(generic name: pregabalin).’ The Supreme Court made a final ruling the use patent of Lyrica was valid on the 14th.

Fees

Pfizer has won the final nullification trial filed by generic companies on the use patent of ‘Lyrica(generic name: pregabalin).’ The Supreme Court made a final ruling the use patent of Lyrica was valid on the 14^th.